ClearPoint Neuro, Inc. (CLPT) vs Avita Medical Inc. (RCEL)

ClearPoint Neuro, Inc. and Avita Medical Inc. are both Medical Devices companies. Avita Medical Inc. is the larger, with a market value of $333.1M against $294.1M — 1.1× the size. ClearPoint Neuro, Inc. grew revenue faster over the last twelve months: 25.9% against 1.00%. Avita Medical Inc. has the higher net margin (−57.0% vs −81.8%) and the lower return on invested capital (−306.2% vs −61.3%). Across the 17 metrics below, Avita Medical Inc. leads on 10 and ClearPoint Neuro, Inc. on 7.

Valuation

Metric CLPT RCEL Medical Devices median
P/E n/m n/m 23.22
P/S 6.47 0.27 2.34
P/B 25.39 n/m 2.33
Price to free cash flow n/m n/m 23.72
EV/EBITDA n/m n/m 11.54
EV/Sales 6.97 1.28 2.24
Earnings yield (13.01%) (220.34%) (10.09%)
Free cash flow yield (11.64%) (126.86%) (8.47%)

Profitability

Metric CLPT RCEL Medical Devices median
Gross margin 62.61% 81.56% 56.01%
Operating margin (73.42%) (49.79%) (15.03%)
Net margin (81.76%) (56.96%) (20.40%)
Free cash flow margin (74.01%) (33.38%) (7.24%)
Return on equity (226.52%) 211.55% (15.32%)
Return on assets (46.21%) (81.36%) (19.72%)
Return on invested capital (61.31%) (306.20%) (10.33%)

Growth

Metric CLPT RCEL Medical Devices median
Revenue growth (TTM) 25.86% 1.00% 8.80%
EPS growth (last fiscal year) (28.57%) 27.02% 29.03%
Revenue growth, 5-year CAGR 23.58% 19.63% 15.47%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CLPT RCEL Medical Devices median
Debt to equity 4.66 (1.68) 0.07
Current ratio 4.74 0.41 2.50
Net debt to EBITDA (0.14) (0.60) 0.49

Dividend

Metric CLPT RCEL Medical Devices median
Dividend yield — — 1.16%
Payout ratio — — 0.36

Size

Metric CLPT RCEL Medical Devices median
Market cap 294.06m 333.10m 167.06m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack